BACKGROUND: Our objective was to evaluate the ac-curacy of cardiovascular disease (CVD) risk score classification by direct LDL cholesterol (dLDL-C), calculated LDL cholesterol (cLDL-C), and non–HDL cholesterol (non–HDL-C) compared to classification by reference measurement procedures (RMPs) per-formed at the CDC. METHODS: We examined 175 individuals, including 138 with CVD or conditions that may affect LDL-C mea-surement. dLDL-C measurements were performed using Denka, Kyowa, Sekisui, Serotec, Sysmex, UMA, and Wako reagents. cLDL-C was calculated by the Friedewald equation, using each manufacturer’s direct HDL-C assay measurements, and total cholesterol and triglyceride measurements by Roche and Siemen
Recent studies have shown that Friedewald underestimates low-density lipoprotein cholesterol (LDL-C)...
Background and aims: Our goals in the study were to (1) quantify the discordance in LDL-C levels bet...
BACKGROUND: The European Atherosclerosis Society- European Federation of Clinical Chemistry and Labo...
BACKGROUND: Our objective was to evaluate the accu-racy of cardiovascular disease (CVD) risk score c...
AIMS: To compare low-density lipoprotein cholesterol (LDL-C) values calculated by the Friedewald equ...
Background Systematic COronary Risk Evaluation (SCORE), the risk estimation system recommended by th...
Objective: Research was aimed at the retrospective analysis of the Non-HDL cholesterol assessment as...
BackgroundAccurate measurement of blood lipids is crucial in cardiovascular disease risk management....
distributor for directly measuringHDL cholesterol (C) and LDL-C were evaluated for imprecision, true...
BACKGROUND: Despite international standardization programs for LDLc and HDLc measurements, results v...
LDL-cholesterol (LDLc) is the main lipid marker in car-diovascular risk estimation and the principal...
Current recommendations of the Adult Treatment Panel and Adolescents Treatment Panel of National Cho...
Background: Validity of Friedewald formula (FF) in patients with serum triglycerides (TGs) <400 mg/d...
BACKGROUND: To compare apolipoprotein B (apoB), non-high-density lipoprotein-cholesterol (non-HDL-c)...
ObjectivesThis study sought to examine patient-level discordance between population percentiles of n...
Recent studies have shown that Friedewald underestimates low-density lipoprotein cholesterol (LDL-C)...
Background and aims: Our goals in the study were to (1) quantify the discordance in LDL-C levels bet...
BACKGROUND: The European Atherosclerosis Society- European Federation of Clinical Chemistry and Labo...
BACKGROUND: Our objective was to evaluate the accu-racy of cardiovascular disease (CVD) risk score c...
AIMS: To compare low-density lipoprotein cholesterol (LDL-C) values calculated by the Friedewald equ...
Background Systematic COronary Risk Evaluation (SCORE), the risk estimation system recommended by th...
Objective: Research was aimed at the retrospective analysis of the Non-HDL cholesterol assessment as...
BackgroundAccurate measurement of blood lipids is crucial in cardiovascular disease risk management....
distributor for directly measuringHDL cholesterol (C) and LDL-C were evaluated for imprecision, true...
BACKGROUND: Despite international standardization programs for LDLc and HDLc measurements, results v...
LDL-cholesterol (LDLc) is the main lipid marker in car-diovascular risk estimation and the principal...
Current recommendations of the Adult Treatment Panel and Adolescents Treatment Panel of National Cho...
Background: Validity of Friedewald formula (FF) in patients with serum triglycerides (TGs) <400 mg/d...
BACKGROUND: To compare apolipoprotein B (apoB), non-high-density lipoprotein-cholesterol (non-HDL-c)...
ObjectivesThis study sought to examine patient-level discordance between population percentiles of n...
Recent studies have shown that Friedewald underestimates low-density lipoprotein cholesterol (LDL-C)...
Background and aims: Our goals in the study were to (1) quantify the discordance in LDL-C levels bet...
BACKGROUND: The European Atherosclerosis Society- European Federation of Clinical Chemistry and Labo...